Related Experiment Video
Updated: Jun 19, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Heart failure as presenting manifestation of cardiac involvement in systemic lupus erythematosus
N E van der Laan-Baalbergen1, S A Mollema, H Kritikos
1Deptartment of Rheumatology, Leiden University Medical Center, the Netherlands.
Insights
Heart failure is a rare but serious complication of systemic lupus erythematosus (SLE). Prompt, aggressive treatment, including immunosuppressants, can lead to excellent long-term outcomes for SLE patients with heart failure.
Area of Science:
- Cardiology
- Rheumatology
- Systemic Lupus Erythematosus
Background:
- Heart failure is an uncommon manifestation of cardiac involvement in systemic lupus erythematosus (SLE).
- The long-term prognosis for SLE patients experiencing heart failure remains largely unknown.
- This study aimed to analyze the long-term outcomes of SLE patients with heart failure as the initial cardiac manifestation.
Observation:
- Six SLE patients presented with heart failure, confirmed by echocardiography showing reduced left ventricular ejection fraction (LVEF) between 23-37%.
- Literature review identified 21 additional cases of SLE-related heart failure, mostly with favorable short-term outcomes.
- The observed patients received aggressive treatment including high-dose glucocorticoids, cytotoxic agents (cyclophosphamide or azathioprine), and IVIG.
Findings:
- Aggressive treatment, including immunosuppressive therapy and inotropic support, led to complete symptom resolution and improved LVEF in the studied SLE patients.
- Mean follow-up was 77 months (range 43-113 months), demonstrating sustained positive outcomes.
- Reported cases indicate that immunosuppressive therapy generally leads to favorable short-term outcomes in SLE-associated heart failure.
Implications:
- Heart failure, though rare, is a life-threatening condition in SLE patients.
- Prompt and aggressive immunosuppressive treatment is crucial for achieving excellent long-term outcomes in SLE-related heart failure.
- Early diagnosis and intervention can significantly improve the prognosis for cardiac involvement in systemic lupus erythematosus.
Background:
Heart failure in systemic lupus erythematosus (SLE ) is rare, and its long-term outcome is unknown. The aim of this study was to analyse the long-term outcome of six SLE patients with heart failure as first manifestation of cardiac involvement and to review previously reported cases.
Methods:
We conducted a retrospective chart review of SLE patients from two tertiary referral centres who presented between 1999 and 2004 with clinical and echocardiographic signs of heart failure as their first manifestation of cardiac involvement. Details of the clinical presentation and follow-up and serial findings at echocardiography were collected. A retrospective review of the literature was performed using the PubMed database.
Results:
Six cases were identified who presented with heart failure, as confirmed by echocardiography (left ventricular ejection fraction (LVEF) ranging from 23 to 37%). Treatment with high-dose glucocorticoids, cytotoxic treatment (azathioprine in one patient, cyclophosphamide in five patients), intravenous immunoglobulins (in one patient) and temporary inotropic support (two patients) resulted in complete resolution of symptoms and improvement of LVEF , with a mean follow-up of 77 months (range 43 to 113). Twenty-one additional cases of heart failure as manifestation of cardiac involvement in SLE have been reported, most with favourable short-term outcome following institution of immunosuppressive therapy.
Conclusions:
Heart failure is a rare but life-threatening manifestation of cardiac involvement in SLE. Long-term outcome can be excellent when aggressive treatment is instituted promptly.
Related Concept Videos
Heart Failure III: Clinical Manifestations
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Rheumatic Heart Disease IV: Nursing Management